Epoch Shares Climb Nearly 10 Percent, Buoyed By Nanogen Patent News | GenomeWeb

NEW YORK, Dec. 1 (GenomeWeb News) - Shares in Epoch Biosciences were up 9.7 percent at $2.37 in mid-afternoon trading, buoyed by a recent patent announcement by corporate suitor Nanogen.


Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.